Oestrogen receptor activity in breast cancer detected at a prevalence screening examination
- 16 Downloads
In view of the possible introduction of screening programmes, this study compares oestrogen receptor (ER) levels in a series of women whose primary tumour was detected by screening and an age-matched consecutive series of women whose tumours were diagnosed after symptomatic presentation. Because of missing data and other statistical considerations, the comparison was made using T1 and T2 categories of tumour only. Some differences were found: the distribution of ER levels was significantly different in the two groups, with more extreme values in the symptomatic series; the screening series, however, had more moderate/rich ER levels than the symptomatic group. Tumours of special pathological type (for example, tubular, cribriform, lobular, medullary, and mucoid) were more likely to be ER-moderate or -rich, and there were more of these tumours in the screening series. The relationship of these findings to tumour growth rate is discussed. The study highlights the difficulty of obtaining sufficient tissue for conventional DCC biochemical assays from the small non-invasive tumours found by screening, and suggests that newer alternative methods employing monoclonal antibodies may be required for such types of tumour.
Key wordsbreast cancer oestrogen receptor pathological type screening
Unable to display preview. Download preview PDF.
- 5.Bridges KG, Keshgegian AA, Mohan Kumar HA, Neal HS: Influence of surgical techniques on oestrogen and progesterone receptor determinations in breast cancer. Cancer 51: 2319–2320, 1983Google Scholar
- 10.Scatchard G: The attractions of protein for small molecules and ions. Ann N Y Acad Sci 51: 660–672, 1949Google Scholar
- 11.Bradford M: A rapid and sensitive method for the quantitation of microgram quantities of protein, utilising the principles of protein dye binding. Analyt Biochem 72: 660–672, 1976Google Scholar
- 13.Anderson TJ, Lamb J, Alexander FE, Roberts MM, Chetty U, Forrest APM, Huggins A, Kirkpatrick AE, Lutz W, Muir BB: Comparative pathology of prevalent and incident cancers detected by screening. Lancet (i) 519–523, 1986Google Scholar
- 15.Azzopardi JG: Problems in breast pathology. In: Bennington JL (ed) Major Problems in Pathology Vol. II London, WB Saunders, 1979Google Scholar
- 16.Holdaway IM, Mountjoy KG: Progesterone and oestrogen receptors in human breast cancer. Aust NZ J Med 8: 630–638, 1978Google Scholar
- 19.Meyer JS: Cell kinetic analysis of human breast carcinoma. In: RW McDivitt, HA Oberman, L Ozello and N Kaufmann (eds) The Breast. IAP Monographs in Pathology No. 25. Williams and Wilkins, Baltimore and London, 1984, pp 45–48Google Scholar
- 21.Simon R: Length biased sampling in etiologic studies. Amer J Epidemiol III: 444–453, 1980Google Scholar
- 24.Hawkins RA, Going J, Teasdale A, Ferguson WA: Oestrogen receptor activity in intraduct and invasive breast carcinoma. Breast Cancer Res Treat. 1987, in pressGoogle Scholar